Buy or sell Lycia Therapeutics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Lycia Therapeutics Stock
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
About Lycia Therapeutics Stock
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Funding History
June 2020 | $50.0M |
---|---|
September 2021 | $70.0M |
Management
Board Member
Timothy Anderson
Board Member
Clare Ozawa
Vice President, Head of Biology
Sarah McWhirter
Chief Scientific Officer
Steve Staben
Founder
Carolyn Bertozzi
Chief Executive Officer
Aetna Wun Trombley
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase